Novartis | NOVN - 이자 수익





이자 수익 변화 날짜
AbbVie USD 59M 13M 2025-12
Almirall EUR 2.71M 580K 2025-12
AstraZeneca USD 73M 62M 2026-03
Autolus Therapeutics Ltd USD 6.14M 1.31M 2025-03
Bayer EUR 130M 38M 2025-09
Biogen USD 37.9M 700K 2026-03
Eli Lilly USD 65M 25M 2025-09
Fresenius Medical Care EUR 13.62M 5.54M 2025-12
Galapagos EUR 12.56M 4.66M 2025-03
Genmab DKK 25M 8M 2025-06
Gilead Sciences USD 95M 7M 2025-12
GlaxoSmithKline GBP 22M 96M 2026-03
GRIFOLS EUR 9.56M 4.5M 2025-06
Hikma Pharmaceutical USD 4M 0 2024-12
J&J USD 2.14 237M 2026-03
Merck EUR 27M 10M 2025-09
Merck USD 69M 27M 2025-12
Pfizer USD 0.62 156M 2025-09
Philips EUR 21M 2M 2025-09
Regeneron Pharmaceuticals USD 193.3M 18.2M 2025-12
Sanofi EUR 33M 81M 2025-12